scholarly journals Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Ezekiel J. Kingston ◽  
Sophia L. Zagora ◽  
Richard J. Symes ◽  
Pushpa Raman ◽  
Peter J. McCluskey ◽  
...  
Keyword(s):  
Mitomycin C ◽  
Xen Gel Stent ◽  
Necrotizing Scleritis

Necrotizing Scleritis After Cosmetic Conjunctivectomy With Mitomycin C

2018 ◽  
Vol 194 ◽  
pp. 72-81 ◽  
Author(s):  
Yong Woo Ji ◽  
Si Yoon Park ◽  
Ji Won Jung ◽  
Seonghee Choi ◽  
Mutlaq Hamad Alotaibi ◽  
...  
Keyword(s):  
Mitomycin C ◽  
Necrotizing Scleritis

Lamellar sclerectomy augmented XEN gel stent glaucoma surgery

2020 ◽  
pp. 112067212092531
Author(s):  
Chih-Hung Kuo
Keyword(s):  
Surgical Technique ◽  
Mitomycin C ◽  
Insertion Site ◽  
Glaucoma Surgery ◽  
Stent Insertion ◽  
Short Term ◽  
Xen Gel Stent ◽  
Major Complications ◽  
Patch Graft ◽  
Scleral Graft

Purpose To describe a surgical technique to optimize XEN gel stent position and its outflow. Methods A small 1- to 1.5-mm square lamellar sclerectomy was created at the external tip of the XEN gel stent implant. The lamellar scleral tissue, served as a patch graft, was secured at the gel stent insertion site. Results Four sequential, unselected, patients with failed primary XEN gel stent surgeries underwent bleb revisions with the technique described. These four patients achieved unmedicated intraocular pressures between 10 and 12 mmHg and a favourable bleb morphology despite repeated mitomycin C applications at 6 months. Conclusion Lamellar sclerectomy with auto-scleral graft augmented XEN gel stent surgery deliver successful short-term outcomes without major complications observed.

scholarly journals Necrotizing scleritis after “pterygium” excision with mitomycin C

2019 ◽  
Vol 97 (S263) ◽  
Author(s):  
Anna Friesacher ◽  
Marco Alder ◽  
Rheinhard Rüesch ◽  
Christophe Valmaggia ◽  
Margarita Todorova
Keyword(s):  
Mitomycin C ◽  
Necrotizing Scleritis ◽  
Pterygium Excision

1570: Combined Mitomycin C and Hyperthermia (SYNERGO) for Patients with Superficial Bladder Cancer (SBC) after Bacillus Calmette-Guerin (BCG) Failure

2007 ◽  
Vol 177 (4S) ◽  
pp. 519-519
Author(s):  
Ofer Nativ ◽  
Renzo Colombo ◽  
Dov Engelstein ◽  
Ofer N. Gofrit ◽  
Thomas Akkad ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Bacillus Calmette Guerin ◽  
Bcg Failure

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

2006 ◽  
Vol 175 (4S) ◽  
pp. 268-269 ◽  
Author(s):  
Jessie L. Au ◽  
Robert A. Badalament ◽  
M. Guillaume Wientjes ◽  
Donn C. Young ◽  
Tong Shen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Long Term Follow Up

Erste Ergebnisse – Die gedeckte Sklerotomie unter primärer Anwendung von Mitomycin C 0,02%

2008 ◽  
Vol 225 (S 04) ◽  
Author(s):  
E Karioris ◽  
C Wirbelauer ◽  
H Häberle ◽  
DT Pham
Keyword(s):  
Mitomycin C ◽  
Erste Ergebnisse

Lokale Applikation von Mitomycin C bei Atemwegsstenosen

Pneumologie ◽  
2009 ◽  
Vol 63 (S 01) ◽  
Author(s):  
PC Bauer ◽  
U Sommerwerck ◽  
J Hagmeyer ◽  
F Bonella ◽  
U Costabel
Keyword(s):  
Mitomycin C

Wundmodulation bei der gedeckten Sklerotomie durch Kombination von Mitomycin-C und subkonjunktivalem Avastin

2011 ◽  
Vol 228 (S 02) ◽  
Author(s):  
AM Hoang ◽  
A Berthold ◽  
A Just ◽  
DT Pham ◽  
C Wirbelauer
Keyword(s):  
Mitomycin C
Sign in / Sign up

Export Citation Format

Share Document